Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases

Congenital Heart Diseases Clinical Trial

Official title: Transition From Adolescents to Adulthood for Patients With Congenital Patients With Congenital Heart Diseases: Impact of a Therapeutic Education Program on Quality of Life

Status Completed

Clinical Trial Summary

The Investigators aim to measure the impact of a transition program in congenital cardiology in terms of health-related quality of life.

Clinical Trial Description

The number of adults with congenital heart diseases (CHD) is increasing. However, many young adults are lost to follow-up even in experienced tertiary care centers. American and European guidelines recommend to improve the management of young adults with CHD. Structured therapeutic education programs are therefore needed to optimize the transfer to adult healthcare. Our tertiary care CHD center recently implemented a transition program and simultaneously investigators decided to measure its impact. Indeed investigators need data from randomized trials in this filed. After previous controlled quality of life studies among children and adults with CHD, investigators chose to use the health-related quality of life (HR-QoL) as primary endpoint in this randomized study to focus on patient related outcomes. The investigators assume that patients who participate in this program will improve their quality of life compared to controls. If investigators demonstrate the benefit of this program, it will have important consequences for patients with CHD and eventually for patients with other chronic medical conditions. ;

Related Conditions & MeSH terms

• Congenital Heart Diseases
• Heart Defects, Congenital
• Heart Diseases

• NCT number: NCT03005626
• Study type: Interventional
• Source: University Hospital, Montpellier
• Status: Completed
• Phase: N/A
• Start date: January 2017
• Completion date: November 16, 2020